Paying for Afrezza®

EXPLORE YOUR OPTIONS

97% OF PATIENTS PAY $35 OR LESS FOR AFREZZA*

Call to find the best cost
assistance program for you.

MannKind Cares

844-323-7399

(M-F, 8am–8pm ET)

4 PAYMENT PATHWAYS:

Approved through
COMMERCIAL
INSURANCE

(through your job or
private plan)

Pay as little as
$35
PER MONTH
with the Afrezza Savings Card**

Approved through
MEDICARE OR
MEDICAID

Pay
$35
OR LESS
PER MONTH

NEW PATIENTS
AGES 6–23

through the Pediatric
Bridge Program†

New patients only. While
pursuing insurance approval.
Expires 12/31/2026.

Pay
$35
PER MONTH

UNINSURED

or do not qualify for
other programs

Pay
$99
PER BOX††

* Based on 2025 prescriptions filled. Your cost depends on your insurance plan and eligibility for cost assistance programs.

** Savings card valid for commercially insured patients only. Not for federal/state programs enrollees. Terms at AfrezzaSavingsCard.com.

† Pediatric Bridge Program available 6/1/26–12/31/26 exclusively through MannKind Cares. Terms at Afrezza.com.

†† Cash pay program $99/box. Void where prohibited.

is here to support
you every step of the way

Helps you find your best cost option based on your insurance or cash pay.

Checks your eligibility for savings cards or bridge programs.

Enrolls you in the right program over the phone.

Arranges home delivery through a network pharmacy.

Provides live training from a Patient Navigator.

We offer in-person* and virtual training appointments.
Call at 844-323-7399 or request online.

*In person training available only in select locations.
Call for details.

*What you pay for Afrezza® will depend on your insurance plan. Each plan has different preferred drug lists and out-of-pocket amounts, and most include an annual deductible. If you haven’t met your deductible, you’ll see higher prices until the deductible is met, then your out-of-pocket cost will likely drop. This offer is available for patients with commercial drug insurance coverage. It is not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. Maximum savings limit applies; patient out-of-pocket expense may vary. If the patient’s health plan does not cover Afrezza® or requires a prior authorization, contact AfrezzaAssist℠ for more information. If approved by the patient’s health plan to take Afrezza®, a patient will pay as little as $35 per month. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Afrezza®. See full Program Terms, Conditions, and Eligibility Criteria.

US-AFR-3081

Read more

What is Afrezza?

Read more

Important Safety Information

What is the most important information I should know about Afrezza? Afrezza can cause serious side effects, including:

Sudden lung problems (bronchospasms). In a study, some Afrezza-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems. Do not use Afrezza if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting Afrezza, your healthcare provider will give you a breathing test to check how your lungs are working.

 

Important Safety Information(cont’d)

Who should not use Afrezza®?

Do not use Afrezza® if you:

  • Are having an episode of low blood sugar (hypoglycemia).
  • Have chronic lung problems such as asthma or COPD.
  • Are allergic to regular human insulin or any of the ingredients in Afrezza®.

What should I tell my healthcare provider before using Afrezza®?

Before using Afrezza®, tell your healthcare provider about all your medical conditions, including if you:

  • Have lung problems such as asthma or COPD.
  • Have or have had lung cancer.
  • Are using any inhaled medications.
  • Smoke or have recently stopped smoking.
  • Have kidney or liver problems.
  • Are pregnant, planning to become pregnant, or are breastfeeding. Afrezza® may harm your unborn or breastfeeding baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins or herbal supplements.

Before you start using Afrezza®, talk to your healthcare provider about low blood sugar and how to manage it.

What should I avoid while using Afrezza®?

While using Afrezza® do not:

  • Drive or operate heavy machinery, until you know how Afrezza® affects you.
  • Drink alcohol or use over-the-counter medicines that contain alcohol.
  • Smoke.

What are the possible side effects of Afrezza®?

Afrezza® may cause serious side effects that can lead to death, including:

See “What is the most important information I should know about Afrezza®?”

  • Low blood sugar (hypoglycemia). Signs and symptoms that may indicate low blood sugar include:
    • Dizziness or light-headedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability or mood change, hunger.
  • Decreased lung function. Your healthcare provider should check how your lungs are working before you start using Afrezza, 6 months after you start using it, and yearly after that.
  • Lung cancer. In studies of Afrezza® in people with diabetes, lung cancer occurred in a few more people who were taking Afrezza® than in people who were taking other diabetes medications. There were too few cases to know if lung cancer was related to Afrezza®. If you have lung cancer, you and your healthcare provider should decide if you should use Afrezza®.
  • Diabetic ketoacidosis. Talk to your healthcare provider if you have an illness. Your Afrezza® dose or how often you check your blood sugar may need to be changed.
  • Severe allergic reaction (whole body reaction). Get medical help right away if you have any of these signs or symptoms of a severe allergic reaction:
    • A rash over your whole body, trouble breathing, a fast heartbeat, or sweating.
  • Low potassium in your blood (hypokalemia).
  • Heart failure. Taking certain diabetes pills called thiazolidinediones or “TZDs” with Afrezza® may cause heart failure in some people. This can happen even if you have never had heart failure or heart problems before. If you already have heart failure it may get worse while you take TZDs with Afrezza®. Your healthcare provider should monitor you closely while you are taking TZDs with Afrezza®. Tell your healthcare provider if you have any new or worse symptoms of heart failure including:
    • Shortness of breath, swelling of your ankles or feet, sudden weight gain.

Treatment with TZDs and Afrezza® may need to be changed or stopped by your healthcare provider if you have new or worse heart failure.

Get emergency medical help if you have:

• Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, confusion.

The most common side effects of Afrezza® include:

  • Low blood sugar (hypoglycemia), cough, sore throat.

These are not all the possible side effects of Afrezza®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088 ).

Please See Full Prescribing Information, including BOXED WARNING, Medication Guide and Instructions for Use for Afrezza.


Afrezza, MannKind, MannKind Cares, and their respective logos are registered trademarks of MannKind Corporation.
© MannKind Corporation May 2026.
This site is intended for use by U.S. residents only.